AUG 19, 2021 6:30 AM PDT

Insights Into the Interplay Between COVID and the Nasal Microbiome

WRITTEN BY: Tara Fernandez

There is a spectrum of COVID symptom severity: some recover after experiencing nothing more than a mild cough, while others end up in intensive care, battling life-threatening consequences of infection. 

We know that older adults are more likely to become severely ill after contracting the virus—the vast majority of COVID deaths occur in those over 65. Additionally, individuals with underlying chronic health conditions and certain ethnic minority groups have disproportionately worse COVID outcomes.

New evidence points to yet another underlying factor that may control COVID outcomes—microorganisms in the nose.

SARS-CoV-2 spreads from person to person through the inhalation of respiratory droplets in the air. The virus begins to divide as soon as it enters the nasal cavity, attaching to ACE2 receptors in the cells lining the upper respiratory tract. However, the factors that block the virus from infecting the lower respiratory tract and triggering severe respiratory disease are not well understood.

To investigate, researchers at the University of California, Irvine, examined the nasal microbiomes of 68 hospitalized COVID patients, 45 healthcare workers, and 21 healthy controls. 

The team found that acute SARS-CoV-2 infections were associated with distinct shifts in the nasal microbiome. In particular, as the coronavirus begins to replicate in the upper respiratory tract, so does the pathogenic bacteria Pseudomonas aeruginosa, which could contribute to the increased incidence of secondary bacterial infections in these patients.

In addition, genetic analyses of the nasal transcriptome highlighted elevated inflammation and diminished tissue repair within the inpatient COVID-19 patient community, which was associated with increased heterogeneity of their nasal microbiome.

Interestingly, healthcare workers were found to have more diverse nasal flora than the healthy control participants. For example, Burkholderia and Acinetobacter species detected in their noses suggest a mechanism for hospital-acquired infections to spread, particularly among vulnerable patients in intensive care. 
 

Source: Cell Reports.


 

About the Author
  • Tara Fernandez has a PhD in Cell Biology and has spent over a decade uncovering the molecular basis of diseases ranging from skin cancer to obesity and diabetes. She currently works on developing and marketing disruptive new technologies in the biotechnology industry. Her areas of interest include innovation in molecular diagnostics, cell therapies, and immunology. She actively participates in various science communication and public engagement initiatives to promote STEM in the community.
You May Also Like
JUL 27, 2021
Health & Medicine
No Link Found Between Vaccinations and Increased Risk of Allergic Diseases
JUL 27, 2021
No Link Found Between Vaccinations and Increased Risk of Allergic Diseases
It is well known that allergies and asthma have been on the rise in developed nations where childhood mass vaccinations ...
AUG 05, 2021
Immunology
Nosedive: Poor Nasal Antiviral Responses Linked to Severe COVID
AUG 05, 2021
Nosedive: Poor Nasal Antiviral Responses Linked to Severe COVID
Talking, singing, coughing—all of these can spread COVID-19 from an infected person via respiratory aerosols. Thes ...
AUG 19, 2021
Cancer
Japanese Berry Vine Could Treat Lung Cancer
AUG 19, 2021
Japanese Berry Vine Could Treat Lung Cancer
A berry-producing vine in Japan has shown promise in mouse models for treating lung cancer. The corresponding study was ...
AUG 24, 2021
Immunology
Women Produce More COVID Antibodies Than Men
AUG 24, 2021
Women Produce More COVID Antibodies Than Men
An exploration into the human immune response after a COVID-19 infection has revealed a surprising finding: women produc ...
OCT 12, 2021
Immunology
Major Landmark in a 100-Year Search for a Malaria Vaccine
OCT 12, 2021
Major Landmark in a 100-Year Search for a Malaria Vaccine
In one of the greatest global health milestones of our time, the World Health Organization has approved the widespread d ...
OCT 18, 2021
Genetics & Genomics
A Decade After Gene Therapy, SCID Patients Are Doing Well
OCT 18, 2021
A Decade After Gene Therapy, SCID Patients Are Doing Well
For decades, scientists have been trying to find ways to cure disorders that can be traced back to an error in one gene. ...
Loading Comments...